Clarifying the effects of race and socioeconomic status on disparities in HPV vac
Project Number1U01IP000636-01
Contact PI/Project LeaderPERKINS, REBECCA BERNSTEIN Other PIs
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): Black, Hispanic and low-income women are more likely to develop and die from cervical cancer than White women. With the introduction of HPV vaccine, clinicians have a remarkable opportunity to reduce these disparities. Unfortunately, minority and low-income women are also less likely to complete the HPV vaccine series. While HPV vaccine uptake is expected to reduce incidence and prevalence of cervical cancer over time, poor uptake of the vaccine by underserved women could actual increase disparities in cervical cancer rates The long-term objective of the proposed study, Clarifying the Effects of Race and Socioeconomic Status on Disparities in HPV Vaccination Rates, is to generate knowledge on which to base interventions to increase uptake of the vaccine among underserved women. The study has three aims:1) to characterize how perceptions of HPV vaccination differ by race and socioeconomic status among White, Black, and Hispanic parents of 11-18 year old girls attending public and private clinics; 2) to characterize providers' perceptions of barriers and facilitators to initiating and completing the HPV vaccine series, specifically focusing on the distinct contributions of race and socioeconomic status; and 3) to use the information gathered in Aims 1 and 2 to develop strategies for improving HPV vaccine initiation and completion overall, with a specific focus on reducing race and income-based disparities in complete vaccination rates. An innovative conceptual model, incorporating the Health Belief Model, the Transtheoretical Model, and the Theory of Planned Behavior will be used. To address the first aim, the investigators will conduct 30-45 minute qualitative interviews with 120 parents of adolescent girls to identify the barriers and facilitators to vaccine series completion. This study will sample Black, Hispanic, and White parents at public and private sites at each of three stages of vaccination: not initiated, incomplete, and complete. To achieve the second aim, 45-90 minute qualitative interviews will be conducted with 20 providers at public and private clinics to characterize knowledge, perceptions and beliefs of providers that serve as facilitators and barriers to HPV vaccine completion. Content analysis based in grounded theory will be used to identify common health beliefs, parental concerns and attitudes about HPV vaccination, social norms, barriers and other factors that influence series initiation and completion. To address the third aim, the investigators will solicit ideas from parents and providers, explore their receptiveness toward school-based solutions that have proved effective in other countries, and convene a meeting of key community stakeholders to discuss implementation of targeted solutions to improve HPV vaccine uptake among diverse groups.
PUBLIC HEALTH RELEVANCE: Black, Hispanic and low-income women are less likely to complete the HPV vaccine series, which could worsen disparities in cervical cancer rates. The proposed project is relevant to public health because it will allow us to explore the independent and additive effects of race and socioeconomic status on HPV vaccination in the adolescent daughters of minority women. We will use qualitative interviews with parents and providers, which allow a deep understanding of the interplay of factors, to identify targets and methodology for successful interventions.
Public Health Relevance Statement
Black, Hispanic and low-income women are less likely to complete the HPV vaccine series, which could worsen disparities in cervical cancer rates. The proposed project is relevant to public health because it will allow us to explore the independent and additive effects of race and socioeconomic status on HPV vaccination in the adolescent daughters of minority women. We will use qualitative interviews with parents and providers, which allow a deep understanding of the interplay of factors, to identify targets and methodology for successful interventions.
National Center for Immunization and Respiratory Diseases
CFDA Code
185
DUNS Number
005492160
UEI
JZ8RQC4EMDZ5
Project Start Date
01-September-2012
Project End Date
31-August-2014
Budget Start Date
01-September-2012
Budget End Date
31-August-2014
Project Funding Information for 2012
Total Funding
$300,000
Direct Costs
$230,238
Indirect Costs
$69,762
Year
Funding IC
FY Total Cost by IC
2012
National Center for Immunization and Respiratory Diseases
$300,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01IP000636-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01IP000636-01
Patents
No Patents information available for 1U01IP000636-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01IP000636-01
Clinical Studies
No Clinical Studies information available for 1U01IP000636-01
News and More
Related News Releases
No news release information available for 1U01IP000636-01
History
No Historical information available for 1U01IP000636-01
Similar Projects
No Similar Projects information available for 1U01IP000636-01